πŸ‡ΊπŸ‡Έ FDA
Patent

US 10844052

LLS compounds for treatment of cancer

granted A61PA61P35/00

Quick answer

US patent 10844052 (LLS compounds for treatment of cancer) held by The Regents of the University of California expires Mon Nov 19 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Nov 24 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 19 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61P, A61P35/00